|
Temps Différé Nasdaq
-
22:00:00 28/03/2023
|
45.12 |
USD
|
|
-1.40%
|
|
|
|
|
|

Toute l'actualité sur PTC THERAPEUTICS, INC. |
|
24/03 | Les actions de PTC Therapeutics chutent après l'annonce du départ du directeur général | MT |
24/03 | Transcript : PTC Therapeutics, Inc. - Special Call | CI |
24/03 | PTC Therapeutics, Inc. annonce des changements de PDG | CI |
24/03 | PTC Therapeutics, Inc. nomme Matthew Klein au conseil d'administration | CI |
17/03 | PTC Therapeutics, Inc. : SVB Securities LLC neutre sur le dossier | ZM |
14/03 | Transcript : PTC Therapeutics, Inc. Presents at Barclays Global Healthcare Co.. | CI |
27/02 | PTC Therapeutics, Inc. : RBC Capital Markets est neutre | ZM |
24/02 | PTC Therapeutics, Inc. : UBS toujours neutre sur le dossier | ZM |
23/02 | PTC Therapeutics, Inc. : Raymond James réitère son opinion positi.. | ZM |
22/02 | PTC Therapeutics, Inc. : Cantor Fitzgerald toujours positif | ZM |
22/02 | PTC Therapeutics, Inc. : RBC Capital Markets maintient son opinio.. | ZM |
21/02 | La perte de PTC Therapeutics se creuse au quatrième trimestre, mais les revenus augment.. | MT |
21/02 | PTC Therapeutics, Inc. annonce ses résultats pour l'année complète se terminant le 31 d.. | CI |
21/02 | Transcript : PTC Therapeutics, Inc., Q4 2022 Earnings Call, Feb 21, 2023 | CI |
21/02 | PTC Therapeutics, Inc. réaffirme ses prévisions de revenus pour l'année 2023 | CI |
21/02 | PTC Therapeutics, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 déc.. | CI |
02/02 | Vente d'initiés : Ptc Therapeutics | MT |
|
|
Actualités dans d'autres langues sur PTC THERAPEUTICS, INC. |
|
28/03 | PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |  |
27/03 | Stuart Peltz, Ph.D., Rare Disease Pioneer, to Retire as Chief Executive Officer of PTC .. |  |
24/03 | PTC Therapeutics Shares Fall After Chief Executive Officer Exit Announcement |  |
24/03 | PTC Therapeutics Chief Executive Stuart Peltz Retiring, Chief Operating Officer Matthew.. |  |
24/03 | Ptc Therapeutics, Inc. : Change in Directors or Principal Officers, Regulation FD Disclosu.. |  |
24/03 | Stuart Peltz, Ph.D., Rare Disease Pioneer, to Retire as Chief Executive Officer of PTC .. |  |
24/03 | PTC Therapeutics, Inc. Announces CEO Changes |  |
24/03 | PTC Therapeutics, Inc. Appoints Matthew Klein to Board of Directors |  |
21/02 | PTC Therapeutics Q4 Loss Widens, Revenue Rises; Reaffirms Full-Year 2023 Revenue Guidan.. |  |
21/02 | PTC THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and.. |  |
|
|
Recommandations des analystes sur PTC THERAPEUTICS, INC. |
|
|
|
|
|
Prochain événement sur PTC THERAPEUTICS, INC.
Evénements à venir dans le secteur
|
|
|
|